サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1561493

スマートピル市場レポート：対象領域、適応疾患、用途、エンドユーザー、地域別、2024年～2032年

Smart Pills Market Report by Target Area, Disease Indication, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 148 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.33円
スマートピル市場レポート：対象領域、適応疾患、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のスマートピルの市場の市場規模は2023年に46億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて6.9%の成長率（CAGR）を示し、2032年までに85億米ドルに達すると予測しています。老年人口の慢性疾患管理需要の増加、急速な技術進歩、低侵襲手術（MIS）の新興動向、個別化医療とドラッグデリバリーに対する製薬業界の注目の高まりなどが、市場を推進する主な要因の一部です。

スマートピルは、デジタルピルや摂取可能なセンサーとしても知られ、遠隔監視やデータ収集を可能にする極小の電子部品を搭載した革新的な医薬品です。これらの錠剤は通常、センサー、マイクロチップ、トランスミッターを内蔵しており、患者が摂取します。体内に入ると体液と相互作用し、患者の健康指標、服薬遵守、生理的反応に関するデータをリアルタイムで外部機器に送信します。ヘルスケアプロバイダーや研究者は、このデータを利用して患者のケアを強化し、治療計画を最適化し、医薬品開発を改善します。スマートピルは、モニタリングとデータ取得の機能を強化することで、個別化医療、慢性疾患管理、臨床試験において潜在的な利益をもたらします。

世界のスマートピルの市場は、世界の高齢化によって慢性疾患の有病率が増加し、患者の健康を継続的に監視・管理する必要があることから、大きな成長を遂げています。スマートピルは、リアルタイムの健康データを収集する非侵襲的で効率的な方法を提供し、遠隔患者モニタリングや疾病管理のための貴重なツールとなっています。さらに、小型化されたエレクトロニクスと無線通信技術の進歩により、スマートピルの開発・製造のコスト効率が向上し、医療提供者と患者へのアクセスが向上したため、市場拡大への明るい見通しが生まれています。これに加えて、個別化医療に対する需要の高まりや、製薬会社や調査研究者がスマートピル技術への投資を促す正確なドラッグデリバリー・システムの必要性が、市場の成長に寄与しています。さらに、COVID-19の大流行が遠隔医療や遠隔監視ソリューションの採用に拍車をかけ、スマートピル市場をさらに押し上げています。

スマートピルの市場傾向/促進要因：

高齢化と慢性疾患管理

重要な促進要因のひとつは、世界中で老年人口が増加していることです。人口の平均年齢が上昇するにつれて、糖尿病、高血圧、心血管疾患などの慢性疾患の有病率も上昇します。これらの疾患を管理するには、継続的なモニタリングと服薬アドヒアランスが必要になることが多いです。スマートピルは、患者の健康指標に関する非侵襲的でリアルタイムのデータ収集を提供することで、革新的なソリューションを提供します。この遠隔モニタリング機能は、従来のモニタリング方法では困難な高齢の患者にとって特に価値があります。ヘルスケア・プロバイダーは、スマートピルからのデータを利用してタイムリーな介入を行い、治療計画を調整し、より良い疾病管理を行うことができます。

現在進行中の技術的進歩

小型化された電子機器、センサー、無線通信技術の進歩は、スマートピルの市場の成長に大きく寄与しています。このような技術の進歩により、より小型で摂取しやすいスマートピルが開発され、患者の快適性とコンプライアンスが向上するとともに、摂取時の不快感や抵抗の可能性が減少しています。さらに、部品の小型化によって製造コストが削減されただけでなく、スマートピルの全体的な効率と寿命も改善されました。その結果、ヘルスケアプロバイダーと患者は、よりアクセスしやすく費用対効果の高いソリューションの恩恵を受ける一方、スマートピルが収集するデータの精度と信頼性が向上したことで、医療界からの受け入れが拡大し、市場拡大の一助となっています。

個別化医療と新規ドラッグデリバリーへの需要の高まり

製薬業界が個別化医療や正確なドラッグ・デリバリー・システムへの関心を高めていることも、市場を牽引する要因の一つです。スマートピルは、体内の標的部位に直接薬剤を投与するユニークな方法を提供します。この標的を絞ったドラッグデリバリーは、副作用を最小限に抑えながら治療効果を高めることができます。製薬会社は医薬品開発を改善する手段としてスマートピル技術への投資を増やしており、個々の患者のニーズに合わせた薬物療法を実現しています。これとは別に、スマートピルは臨床試験で使用することができ、薬の効果に関するリアルタイムのデータを収集することで、調査プロセスを合理化し、新しい治療法の市場導入を早める可能性があります。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のスマートピル市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：対象領域別

  • 食道
    • 市場動向
    • 市場予測
  • 小腸
    • 市場動向
    • 市場予測
  • 大腸
    • 市場動向
    • 市場予測
  • 胃
    • 市場動向
    • 市場予測

第7章 市場内訳：適応疾患別

  • 食道疾患
    • 市場動向
    • 市場予測
  • 小腸疾患
    • 市場動向
    • 市場予測
  • 大腸疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • カプセル内視鏡
    • 市場動向
    • 市場予測
  • ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 患者モニタリング
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • 調査機関
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • CapsoVision Inc.
    • Check-Cap Ltd.
    • General Electric Company
    • IntroMedic Co. Ltd.
    • Jinshan Science & Technology（Group）Co. Ltd.
    • Koninklijke Philips N.V.
    • Medtronic plc
    • Olympus Corporation
    • PENTAX Medical（Hoya Corporation）
図表

List of Figures

  • Figure 1: Global: Smart Pills Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Pills Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Smart Pills Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Smart Pills Market: Breakup by Target Area (in %), 2023
  • Figure 5: Global: Smart Pills Market: Breakup by Disease Indication (in %), 2023
  • Figure 6: Global: Smart Pills Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Smart Pills Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Smart Pills Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Smart Pills (Esophagus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Smart Pills (Esophagus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Smart Pills (Small Intestine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Smart Pills (Small Intestine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Smart Pills (Large Intestine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Smart Pills (Large Intestine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Smart Pills (Stomach) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Smart Pills (Stomach) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Smart Pills (Esophageal Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Smart Pills (Esophageal Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Smart Pills (Small Bowel Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Smart Pills (Small Bowel Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Smart Pills (Colon Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Smart Pills (Colon Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Smart Pills (Other Disease Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Smart Pills (Other Disease Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Smart Pills (Capsule Endoscopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Smart Pills (Capsule Endoscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Smart Pills (Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Smart Pills (Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Smart Pills (Patient Monitoring) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Smart Pills (Patient Monitoring) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Smart Pills (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Smart Pills (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Smart Pills (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Smart Pills (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Smart Pills (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Smart Pills (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Smart Pills Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Smart Pills Industry: SWOT Analysis
  • Figure 87: Global: Smart Pills Industry: Value Chain Analysis
  • Figure 88: Global: Smart Pills Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Pills Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Smart Pills Market Forecast: Breakup by Target Area (in Million US$), 2024-2032
  • Table 3: Global: Smart Pills Market Forecast: Breakup by Disease Indication (in Million US$), 2024-2032
  • Table 4: Global: Smart Pills Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Smart Pills Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Smart Pills Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Smart Pills Market: Competitive Structure
  • Table 8: Global: Smart Pills Market: Key Players
目次
Product Code: SR112024A4568

The global smart pills market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032. The increased demand for chronic disease management among the geriatric population, rapid technological advancements, emerging trend of minimally invasive surgeries (MIS), the increasing focus of pharmaceutical industry on personalized medicine and drug delivery are some of the major factors propelling the market.

Smart pills, also known as digital pills or ingestible sensors, are innovative pharmaceuticals equipped with tiny electronic components that enable remote monitoring and data collection. These pills typically contain sensors, microchips, and transmitters, which are ingested by patients. Once inside the body, they interact with bodily fluids, sending real-time data about a patient's health metrics, medication adherence, and physiological responses to external devices. Healthcare providers and researchers use this data to enhance patient care, optimize treatment plans, and improve drug development. Smart pills offer potential benefits in personalized medicine, chronic disease management, and clinical trials by enhancing monitoring and data acquisition capabilities.

The global smart pills market is experiencing substantial growth driven by the aging population across the globe has resulted in an increased prevalence of chronic diseases, requiring continuous monitoring and management of patient's health. Smart pills offer a non-invasive and efficient way to collect real-time health data, making them a valuable tool for remote patient monitoring and disease management. Moreover, advancements in miniaturized electronics and wireless communication technologies have made it more cost-effective to develop and produce smart pills, increasing their accessibility to healthcare providers and patients, which is creating a positive outlook for market expansion. In addition to this, the rising demand for personalized medicine and the need for precise drug delivery systems prompting pharmaceutical companies and researchers to invest in smart pill technology, are contributing to the market growth. Furthermore, the COVID-19 pandemic has fueled the adoption of telehealth and remote monitoring solutions, further boosting the market for smart pills.

Smart Pills Market Trends/Drivers:

Aging population and chronic disease management

One significant driver is the increasing geriatric population across the globe. As the average age of the population rises, so does the prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases. Managing these conditions often requires continuous monitoring and medication adherence. Smart pills provide an innovative solution by offering non-invasive, real-time data collection on a patient's health metrics. This remote monitoring capability is particularly valuable for elderly patients who may have difficulty with conventional monitoring methods. Healthcare providers can use the data from smart pills to make timely interventions, adjust treatment plans, and ensure better disease management, improving the quality of care for aging populations.

Ongoing technological advancements

Advancements in miniaturized electronics, sensors, and wireless communication technologies have significantly contributed to the growth of the smart pills market. These technological strides have led to the development of smaller, more easily ingestible smart pills, enhancing patient comfort and compliance while reducing the potential for discomfort or resistance during ingestion. Moreover, the miniaturization of components has not only reduced manufacturing costs but also improved the overall efficiency and longevity of smart pills. As a result, healthcare providers and patients benefit from more accessible and cost-effective solutions, while the enhanced accuracy and reliability of the data collected by smart pills have garnered increased acceptance within the medical community, aiding in market expansion.

Growing demand for personalized medicine and novel drug delivery

The pharmaceutical industry's growing interest in personalized medicine and precise drug delivery systems is another driving factor. Smart pills offer a unique way to administer medications directly to the target site in the body. This targeted drug delivery can enhance the efficacy of treatments while minimizing side effects. Pharmaceutical companies are increasingly investing in smart pill technology as a means to improve drug development, ensuring that medications are tailored to individual patient needs. Apart from this, smart pills can be used in clinical trials to gather real-time data on the drug's effects, streamlining the research process and potentially speeding up the introduction of new therapies to the market.

Smart Pills Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on target area, disease indication, application and end user.

Breakup by Target Area:

  • Esophagus
  • Small Intestine
  • Large Intestine
  • Stomach

Small intestine dominate the market

The report has provided a detailed breakup and analysis of the market based on the target area. This includes esophagus, small intestine, large intestine, and stomach. According to the report, small intestine represented the largest segment.

The demand for smart pills targeting the small intestine is propelled by their unique ability to access and monitor this specific area of the digestive tract. The small intestine plays a crucial role in nutrient absorption, making it a focal point for various gastrointestinal disorders and drug delivery challenges. Smart pills designed to operate in this region offer precise insights into nutrient absorption efficiency, allowing for tailored dietary recommendations and treatments for conditions, such as malabsorption syndromes. Furthermore, their application extends to drug delivery optimization, ensuring medications reach the intended site of action, which is especially relevant for treatments that require absorption in the small intestine. As a result, the demand for smart pills tailored to the small intestine continues to rise, driven by their potential to address specific healthcare needs and enhance therapeutic outcomes.

Breakup by Disease Indication:

  • Esophageal Diseases
  • Small Bowel Diseases
  • Colon Diseases
  • Others

A detailed breakup and analysis of the market based on the disease indication have also been provided in the report. This includes esophageal diseases, small bowel diseases, colon diseases, and others.

The surging demand for smart pills in addressing esophageal, small bowel, and colon diseases owing to their capacity to provide precise, real-time data in these specific areas of the gastrointestinal tract is strengthening the market growth. Moreover, the growing prevalence of esophageal diseases such as gastroesophageal reflux disease (GERD), wherein smart pills help monitor pH levels and track acid reflux patterns, aiding in the diagnosis and management of these conditions. Apart from this, in small bowel diseases like Crohn's disease or celiac disease, these pills can help track the passage and transit time, enabling clinicians to assess motility and inflammation, while in colon diseases, particularly colorectal cancer screening, smart pills equipped with imaging capabilities can capture detailed images, enhancing early detection and reducing the need for invasive procedures. This targeted monitoring and diagnostic potential are propelling the demand for smart pills in the context of esophageal, small bowel, and colon diseases, improving patient care and outcomes.

Breakup by Application:

  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring

Capsule endoscopy dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes capsule endoscopy, drug delivery, and patient monitoring. According to the report, capsule endoscopy represented the largest segment.

Unlike traditional endoscopy, smart pills equipped with imaging technology provide a painless and patient-friendly alternative for visualizing the gastrointestinal tract. This has led to increased acceptance and patient compliance, especially in cases where traditional endoscopy may be uncomfortable or challenging. Additionally, capsule endoscopy using smart pills is particularly valuable for diagnosing and monitoring conditions such as obscure gastrointestinal bleeding, Crohn's disease, and small bowel tumors. The high-quality images and real-time data captured by these smart pills allow for early detection and precise localization of abnormalities, thereby facilitating timely interventions and improving patient outcomes. Consequently, the demand for smart pills in capsule endoscopy continues to grow, enhancing the diagnostic capabilities of healthcare professionals and patient experiences.

Breakup by End User:

  • Hospitals
  • Diagnostic Centers
  • Research Institutes

Diagnostic centers hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, diagnostic centers, and research institutes. According to the report, diagnostic centers accounted for the largest market share.

The rising demand for smart pills in diagnostic centers is bolstering market expansion by offering a patient-friendly, non-invasive approach to enhance diagnostic procedures. These devices provide real-time gastrointestinal data, aiding precise diagnoses, especially for conditions like gastrointestinal bleeding, motility disorders, and small bowel diseases. Smart pills' imaging capabilities, pH assessment, and transit monitoring provide clinicians with a comprehensive view of GI health, reducing the need for uncomfortable invasive procedures. This improves patient comfort, compliance, and diagnostic accuracy, benefiting both patients and healthcare providers, and contributing to the growing adoption of smart pills in diagnostic centers.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest smart pills market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's robust healthcare infrastructure, including advanced diagnostic centers and research institutions, is facilitating the adoption of smart pills for innovative diagnostic and research purposes. Concurrently, the increasing prevalence of gastrointestinal disorders, such as inflammatory bowel disease and colorectal cancer, has created a high demand for non-invasive diagnostic tools like smart pills, which offer improved patient comfort and compliance. Moreover, the region's aging population, with a growing need for chronic disease management, sees smart pills as an invaluable solution for remote patient monitoring. Besides this, favorable reimbursement policies and regulatory frameworks in North America are encouraging healthcare providers and pharmaceutical companies to invest in smart pill technology. Apart from this, the region's technological innovation and early market entry by leading companies have established a strong foundation for the growth of the North America smart pills market.

Competitive Landscape:

The global smart pills market presents a competitive landscape characterized by a mix of established players and emerging entrants striving to capitalize on the growing demand for remote patient monitoring and innovative healthcare solutions. Leading companies hold substantial market shares, primarily due to their early market entry, robust R&D capabilities, and extensive distribution networks. They offer a diverse range of smart pill products, incorporating advanced sensor technologies and data analytics platforms. Moreover, partnerships and collaborations with healthcare providers and pharmaceutical companies have further solidified their market position. At the same time, numerous startups and smaller companies, are actively contributing to market growth with disruptive technologies and novel applications of smart pills, intensifying competition and driving innovation in the industry.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • CapsoVision Inc
  • Check-Cap Ltd.
  • General Electric Company
  • IntroMedic Co. Ltd.
  • Jinshan Science & Technology (Group) Co. Ltd.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Olympus Corporation
  • PENTAX Medical (Hoya Corporation).

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

  • In 2020, CapsoVision Inc. (US) attained ISO 27001 security certification for both its headquarters and CapsoCloud software, reaffirming its unwavering dedication to safeguarding customer data.

Key Questions Answered in This Report:

  • How has the global smart pills market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global smart pills market?
  • What is the impact of each driver, restraint, and opportunity on the global smart pills market?
  • What are the key regional markets?
  • Which countries represent the most attractive smart pills market?
  • What is the breakup of the market based on the target area?
  • Which is the most attractive target area in the smart pills market?
  • What is the breakup of the market based on the disease indication?
  • Which is the most attractive disease indication in the smart pills market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the smart pills market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the smart pills market?
  • What is the competitive structure of the global smart pills market?
  • Who are the key players/companies in the global smart pills market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Pills Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Target Area

  • 6.1 Esophagus
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Intestine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Large Intestine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Stomach
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Disease Indication

  • 7.1 Esophageal Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Small Bowel Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colon Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Capsule Endoscopy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Delivery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Patient Monitoring
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 CapsoVision Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Check-Cap Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 General Electric Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 IntroMedic Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Jinshan Science & Technology (Group) Co. Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Koninklijke Philips N.V.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Olympus Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PENTAX Medical (Hoya Corporation)
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio